SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-24-005893
Filing Date
2024-04-26
Accepted
2024-04-26 16:02:09
Documents
6
Period of Report
2024-06-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20240624xdef14a.htm DEF 14A 726142
2 GRAPHIC tmb-20240624xdef14a001.jpg GRAPHIC 7845
3 GRAPHIC tmb-20240624xdef14a013.jpg GRAPHIC 1294
4 GRAPHIC tmb-20240624xdef14a015.jpg GRAPHIC 4550
5 GRAPHIC tmb-20240624xdef14a016.jpg GRAPHIC 3667
6 GRAPHIC tmb-20240624xdef14a017.jpg GRAPHIC 5220
  Complete submission text file 0001558370-24-005893.txt   759127
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40237 | Film No.: 24883420
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)